This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2020 Nov;33(6):e14449.

doi: 10.1111/dth.14449. Epub 2020 Nov 7.

CD147 inhibitors as a treatment for melanoma: Promising agents against SARS-CoV-2 infection

Mohammad Reza Pourani¹, Sayyed Mojtaba Nekooghadam², Leila Youssefian^{3

4}, Hassan Vahidnezhad^{3

4}, Fahimeh Abdollahimajd^{1

5}

Affiliations

Affiliations

¹ Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
² Internal Department of Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
³ Jefferson Institute of Molecular Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
⁴ Department of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
⁵ Clinical Research Development Unit, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

PMID: 33098610
PMCID: PMC7645877
DOI: 10.1111/dth.14449

CD147 inhibitors as a treatment for melanoma: Promising agents against SARS-CoV-2 infection

Mohammad Reza Pourani et al. Dermatol Ther. 2020 Nov.

. 2020 Nov;33(6):e14449.

doi: 10.1111/dth.14449. Epub 2020 Nov 7.

Authors

Mohammad Reza Pourani¹, Sayyed Mojtaba Nekooghadam², Leila Youssefian^{3

4}, Hassan Vahidnezhad^{3

4}, Fahimeh Abdollahimajd^{1

5}

Affiliations

¹ Skin Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
² Internal Department of Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
³ Jefferson Institute of Molecular Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
⁴ Department of Dermatology and Cutaneous Biology, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
⁵ Clinical Research Development Unit, Shohada-e Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

PMID: 33098610
PMCID: PMC7645877
DOI: 10.1111/dth.14449

No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no potential conflict of interest.

Similar articles

Tumor markers as an entry for SARS-CoV-2 infection?
Xia P, Dubrovska A. Xia P, et al. FEBS J. 2020 Sep;287(17):3677-3680. doi: 10.1111/febs.15499. Epub 2020 Aug 28. FEBS J. 2020. PMID: 32738184 Free PMC article. Review.
The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies.
Zalpoor H, Akbari A, Samei A, Forghaniesfidvajani R, Kamali M, Afzalnia A, Manshouri S, Heidari F, Pornour M, Khoshmirsafa M, Aazami H, Seif F. Zalpoor H, et al. Cell Mol Biol Lett. 2022 Feb 2;27(1):10. doi: 10.1186/s11658-022-00311-1. Cell Mol Biol Lett. 2022. PMID: 35109786 Free PMC article. Review.
Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein.
Ragotte RJ, Pulido D, Donnellan FR, Hill ML, Gorini G, Davies H, Brun J, McHugh K, King LDW, Skinner K, Miura K, Long CA, Zitzmann N, Draper SJ. Ragotte RJ, et al. mSphere. 2021 Aug 25;6(4):e0064721. doi: 10.1128/mSphere.00647-21. Epub 2021 Aug 11. mSphere. 2021. PMID: 34378982 Free PMC article.
Alopecia areata in a patient with SARS-Cov-2 infection.
Sgubbi P, Savoia F, Calderoni O, Longo R, Stinchi C, Tabanelli M. Sgubbi P, et al. Dermatol Ther. 2020 Nov;33(6):e14295. doi: 10.1111/dth.14295. Epub 2020 Sep 21. Dermatol Ther. 2020. PMID: 32909635 No abstract available.
SARS-CoV-2 virus infection: Targets and antiviral pharmacological strategies.
Campos DMO, Fulco UL, de Oliveira CBS, Oliveira JIN. Campos DMO, et al. J Evid Based Med. 2020 Nov;13(4):255-260. doi: 10.1111/jebm.12414. Epub 2020 Oct 14. J Evid Based Med. 2020. PMID: 33058394 Free PMC article. No abstract available.

See all similar articles

Cited by

Differential CD147 Functional Epitopes on Distinct Leukocyte Subsets.
Pata S, Surinkaew S, Takheaw N, Laopajon W, Chuensirikulchai K, Kasinrerk W. Pata S, et al. Front Immunol. 2021 Aug 4;12:704309. doi: 10.3389/fimmu.2021.704309. eCollection 2021. Front Immunol. 2021. PMID: 34421910 Free PMC article.
Androgenetic alopecia and COVID-19: A review of the hypothetical role of androgens.
Moravvej H, Pourani MR, Baghani M, Abdollahimajd F. Moravvej H, et al. Dermatol Ther. 2021 Jul;34(4):e15004. doi: 10.1111/dth.15004. Epub 2021 Jun 9. Dermatol Ther. 2021. PMID: 34033224 Free PMC article. Review.

References

1. Jean S‐S, Lee P‐I, Hsueh P‐R. Treatment options for COVID‐19: the reality and challenges. J Microbiol Immunol Infect. 2020;53:436‐443. - PMC - PubMed
1. Rodrigues‐Diez RR, Tejera‐Muñoz A, Marquez‐Exposito L, et al. Statins: could an old friend help the fight against COVID‐19? Br J Pharmacol. 2020;177:4873‐4886. - PMC - PubMed
1. Ulrich H, Pillat MM. CD147 as a target for COVID‐19 treatment: suggested effects of azithromycin and stem cell engagement. Stem Cell Rev Rep. 2020;1‐7. 10.1007/s12015-020-09976-7. [Epub online ahead of print]. - DOI - PMC - PubMed
1. Lian C, Guo Y, Zhang J, Chen X, Peng C, . Targeting CD147 is a novel strategy for antitumor therapy. Curr Pharm Des. 2017;23(29):4410‐4421. - PubMed
1. Peng C, Chen X. CD147 is a novel chemotherapy or prevention target in melanoma. J Investig Dermatol Symp Proc. 2018;19(2):S91‐S93. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal